These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 9086367)

  • 1. [Experimental study of methamphetamine psychosis--role of glutamate and nitric oxide in methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain].
    Abekawa T
    Hokkaido Igaku Zasshi; 1997 Jan; 72(1):113-26. PubMed ID: 9086367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens.
    Abekawa T; Ohmori T; Koyama T
    Brain Res; 1994 Apr; 643(1-2):276-81. PubMed ID: 7518327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nitric oxide synthesis inhibition on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain.
    Abekawa T; Ohmori T; Koyama T
    J Neural Transm (Vienna); 1996; 103(6):671-80. PubMed ID: 8836929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
    Gagnaire F; Chalansonnet M; Carabin N; Micillino JC
    Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methamphetamine-elicited alterations of dopamine- and serotonin-metabolite levels within mu-opioid receptor knockout mice: a microdialysis study.
    Lan KC; Ma T; Lin-Shiau SY; Liu SH; Ho IK
    J Biomed Sci; 2008 May; 15(3):391-403. PubMed ID: 17934798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux.
    Stephans SE; Yamamoto BK
    Synapse; 1994 Jul; 17(3):203-9. PubMed ID: 7974204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
    Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
    Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential new insights into the molecular mechanisms of methamphetamine-induced neurodegeneration.
    Wrona MZ; Yang Z; Zhang F; Dryhurst G
    NIDA Res Monogr; 1997; 173():146-74. PubMed ID: 9260188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine.
    Taraska T; Finnegan KT
    J Pharmacol Exp Ther; 1997 Feb; 280(2):941-7. PubMed ID: 9023310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-2-(4-aminophenyl)ethyladenosine (APNEA), a putative adenosine A3 receptor agonist, enhances methamphetamine-induced dopamine outflow in rat striatum.
    Gołembiowska K; Zylewska A
    Pol J Pharmacol; 1998; 50(4-5):299-305. PubMed ID: 10091714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of nitric oxide on central dopaminergic neurons].
    Nakahara K; Yokoo H; Yoshida M; Tanaka M; Shigemori M
    No To Shinkei; 1994 Dec; 46(12):1147-53. PubMed ID: 7893532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of conditioned fear stress on monoaminergic systems in the rat brain].
    Inoue T
    Hokkaido Igaku Zasshi; 1993 May; 68(3):377-90. PubMed ID: 7686527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in dopamine, serotonin and their metabolites in discrete brain areas of rat offspring after in utero exposure to cocaine or related drugs.
    Henderson MG; McMillen BA
    Teratology; 1993 Nov; 48(5):421-30. PubMed ID: 7508151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleus accumbens serotonin1A receptors control cocaine-induced hyperactivity but not local serotonin increase: an in vivo microdialysis study.
    Müller CP; Thönnessen H; De Souza Silva MA; Fink H; Bert B; Carey RJ; Huston JP
    Neuropharmacology; 2004 Aug; 47(2):205-15. PubMed ID: 15223299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regionally specific changes in central brain monoamine levels by 2,4-dichlorophenoxyacetic acid in acute treated rats.
    Bortolozzi A; Duffard RO; Rubio M; Sturtz N; Evangelista de Duffard AM
    Neurotoxicology; 1998 Dec; 19(6):839-51. PubMed ID: 9863773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NG-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release.
    Inoue H; Arai I; Shibata S; Watanabe S
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1424-30. PubMed ID: 8667206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine-induced selective dopaminergic neurotoxicity is accompanied by an increase in striatal nitrate in the mouse.
    Anderson KL; Itzhak Y
    Ann N Y Acad Sci; 2006 Aug; 1074():225-33. PubMed ID: 17105919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat.
    Gobert A; Rivet JM; Lejeune F; Newman-Tancredi A; Adhumeau-Auclair A; Nicolas JP; Cistarelli L; Melon C; Millan MJ
    Synapse; 2000 Jun; 36(3):205-21. PubMed ID: 10819900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS; Starr MS
    Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals.
    Fusa K; Takahashi I; Watanabe S; Aono Y; Ikeda H; Saigusa T; Nagase H; Suzuki T; Koshikawa N; Cools AR
    Neuroscience; 2005; 130(3):745-55. PubMed ID: 15590157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.